VALN Earnings — Valneva SE American Depositary Shares Post-ER Performance | BigEarnings
VALN — Valneva SE American Depositary Shares
XNAS · Healthcare · Biotechnology
Price$6.30
Market Cap$601.2M
P/E—
52W Range$5.06 – $12.25
Next Earnings2026-08-11
About Valneva SE American Depositary Shares
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
